Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canal

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Chemical Communications (Cambridge, England)|April 20, 2006
From the reactivity of N-heterocyclic carbenes to new chemistry in ionic liquidsJohn P Canal, Taramatee Ramnial, Diane A Dickie, et al.
Dalton Transactions (Cambridge, England : 2003)|February 29, 2008
Synthesis and structure of two tetranuclear osmium carbonyl isotopomers: a crystallographic isotope effectJohn P Canal, Michael Jennings, Glenn P A Yap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: pharmacokinetic and pharmacodynamic evaluationS Guichard, A Montazeri, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in miceS Guichard, E Chatelut, I Lochon, et al.
Cancer Research|December 15, 1994
Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patientsL P Rivory, E Chatelut, P Canal, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|March 1, 1986
Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosisH Hachem, G Favre, G Raynal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinomaP Canal, R Bugat, C Michel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 1998
Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopyC Joqueviel, R Martino, V Gilard, et al.
Journal De Biologie Buccale|June 1, 1989
[An epidemiologic study of the oro-dental health status of children in the region of Ile de France]M L Boy-Lefevre, P Canal, A Bery, et al.
Bulletin Du Cancer|January 1, 1989
[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time]E Chatelut, P Canal, M De Forni, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Chemical Communications (Cambridge, England)|April 20, 2006
From the reactivity of N-heterocyclic carbenes to new chemistry in ionic liquidsJohn P Canal, Taramatee Ramnial, Diane A Dickie, et al.
Dalton Transactions (Cambridge, England : 2003)|February 29, 2008
Synthesis and structure of two tetranuclear osmium carbonyl isotopomers: a crystallographic isotope effectJohn P Canal, Michael Jennings, Glenn P A Yap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: pharmacokinetic and pharmacodynamic evaluationS Guichard, A Montazeri, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in miceS Guichard, E Chatelut, I Lochon, et al.
Cancer Research|December 15, 1994
Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patientsL P Rivory, E Chatelut, P Canal, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|March 1, 1986
Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosisH Hachem, G Favre, G Raynal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinomaP Canal, R Bugat, C Michel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 1998
Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopyC Joqueviel, R Martino, V Gilard, et al.
Journal De Biologie Buccale|June 1, 1989
[An epidemiologic study of the oro-dental health status of children in the region of Ile de France]M L Boy-Lefevre, P Canal, A Bery, et al.
Bulletin Du Cancer|January 1, 1989
[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time]E Chatelut, P Canal, M De Forni, et al.
Pageof 15